skip to Main Content
ahm[at]bwh.harvard.edu
Leukocytes And Con A(+) Angiogenic Vessels In IL-1β–implanted Corneas
Leukocytes And Con A(+) Angiogenic Vessels In IL-1β–implanted Corneas
Plastic Pellet With Cytokines Inserted Into Cornea To Activate Neovascularization
Normal Aorta (left) And Diabetic Aorta (right)
MOLECULAR BIOMARKERS NANO-IMAGING LABORATORY

We develop and employ novel molecular nano-imaging technologies in early disease diagnosis, precise phenotyping, and therapeutic intervention.

In the past decade, we established a novel in vivo nano-imaging technology that allows detection of single molecules in a living organism. This technology enables identification and validation of molecular biomarkers and is a powerful tool for subclinical detection and effective guidance of treatment. We are applying it to a wide range of diseases, including diabetes complications, and cancer. Our imaging technology is cost-effective and has a favorable safety profile that facilitates its translation to the clinic.

Back To Top